AGP Executive Report
Last update: 9 hours agoGMP & Quality Ops: InstantGMP rolled out agentic AI inside its InstantGMP platform so manufacturers can ask natural-language questions and get cross-module answers on deviations, CAPAs, batch status, and inspection readiness in minutes. FDA & Patient Safety: GE HealthCare recalled certain Optima XR Mobile Digital-Ready radiographic systems after column replacement work may skip safety testing, risking arm drop and potential patient injury. Medicare Access Fight: A Senate vote blocked Democrats’ effort to end the Medicare AI prior authorization pilot (WISeR), keeping the program alive while opponents vow to continue. Public Health Targets: China released its 2026–30 health plan aiming to curb chronic disease and raise life expectancy to 80 by 2030, alongside stronger smoking-cessation goals and expanded fertility/childcare services. Long COVID Treatment Research: UK researchers launched a randomized platform trial testing rivaroxaban, colchicine, and antihistamine-loratidine for persistent post-acute COVID fatigue. Diagnostics & Care Delivery: Radiology Partners named Matt Peterson to lead clinical services, while a study warned many incidental breast masses on emergency chest CTs are missed, delaying cancer diagnosis. Identity Verification in Benefits: Medi Assist integrated Aadhaar Offline Verification into health benefits platforms to reduce paperwork and identity misuse risk. Dengue Vaccine Milestone (India): CDSCO approved Takeda’s Qdenga for ages 4–60, marking India’s first dengue vaccine authorization.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.